On the other hand, Huntzicker and coauthors described how Notch1 inhibition altered the proportion of tumor types, reducing HCC-like tumors and increasing cholangiocarcinoma-like tumors [11]. Here, NOTCH1 is linked to hepatocellular carcinoma.